BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  ImPact Biotech Presents Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2024

  December 4, 2024

   · 

  4 min read
• Press Releases

  Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome

  December 4, 2024

   · 

  8 min read
• Press Releases

  Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

  December 4, 2024

   · 

  9 min read
• Press Releases

  Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur

  December 4, 2024

   · 

  6 min read
• Press Releases

  Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

  December 4, 2024

   · 

  9 min read
• Press Releases

  Codetta Bio Welcomes Paul McEwan and Mitch Levine as Independent Board Members

  December 4, 2024

   · 

  3 min read
• Press Releases

  Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

  December 4, 2024

   · 

  7 min read
• Press Releases

  Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza

  December 4, 2024

   · 

  4 min read
• Press Releases

  Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

  December 4, 2024

   · 

  6 min read
• Press Releases

  Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS

  December 4, 2024

   · 

  6 min read